- Patients
- Clinical Research
- Clinical trials
- MK2870-005
2024-08-28T05:44:35.895Z
MK2870-005
MK2870-005
Endometrial cancer
A Phase 3, Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician's Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Immunotherapy
A Phase 3, Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician's Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Immunotherapy
Trial overview
Clinical Area
Medical Oncology
Disease / Condition
Endometrial cancer
Study Location
III
Trial Identifiers